Merit Medical Systems, Inc. (MMSI) News
Follow Merit Medical Systems, Inc. (MMSI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 19 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Merit Medical Systems Reports Quarterly Results
Merit Medical Systems reported results for the quarter ended September 30.
EQUITY | Oct 29, 2026, 10:44 PM UTC
M
Merit Medical Systems Reports Q3 Adjusted EPS of $1.12 per Share
Q3 adjusted EPS was $1.12 per share, versus the FactSet estimate of $1.04.
EARNINGS | Oct 29, 2026, 08:30 PM UTC
M
Merit Medical Systems Reports Third-Quarter 2026 Results
Revenue rose 8.4% year over year to $416.2 million, net income increased 52.4% to $42.3 million, and diluted EPS was $0.70, up from $0.46.
EQUITY | Oct 29, 2026, 08:23 PM UTC
M
Merit Medical Acquires Solo Pace, Expanding Cardiac Therapies Platform
Merit Medical Systems said it acquired Solo Pace, Inc., expanding its cardiac therapies platform with TAVR pacing technology.
EQUITY | Oct 29, 2026, 08:07 PM UTC
L
Merit Medical Price Target Maintained With a $101.00/Share by Needham
Ratings actions from Benzinga
NEWS | Sep 29, 2026, 10:06 AM UTC
L
Needham reiterates Buy rating on Merit Medical Systems, $101 price target
Needham reiterated their Buy rating on Merit Medical Systems's stock with a price target of $101.00.The price target implies an upside of 16.1% from the Sep 28 close of $87.Key takeaways from the analyst noteStrong Reven
EQUITY | Sep 29, 2026, 09:55 AM UTC
H
MMSI: Strategic planning and robust growth drive optimism, with evolving platforms and global focus
Leadership transition has been smooth, with robust Q2 growth and a strategic plan nearing completion. Financial guidance remains conservative, while product and regional strategies focus on evolving platforms, expanding
GEOPOLITICS | Sep 10, 2026, 02:11 PM UTC
L
MMSI: Strategic planning and robust growth position the company for continued expansion and operational maturity
Leadership transition has been smooth, with continued strong financial performance and a rigorous strategic planning process nearing completion. Robust growth is seen in key product lines and regions, especially Europe a
GEOPOLITICS | Sep 10, 2026, 01:48 PM UTC
L
Merit Medical management to participate in September investor conferences
Merit Medical Systems says management is scheduled to participate in the Wells Fargo 2026 Healthcare Conference and other upcoming investor conferences in September.
EQUITY | Sep 04, 2026, 01:27 PM UTC
L
MMSI - Merit Medical to Participate in Upcoming Investors Conferences in September
MMSI - Merit Medical to Participate in Upcoming Investors Conferences in September
EQUITY | Sep 04, 2026, 01:25 PM UTC
L
Merit Medical announces global operations leadership transition
Merit Medical announces a global operations leadership transition; no additional catalyst, effective date, or financial impact was supplied.
EQUITY | Aug 19, 2026, 08:05 PM UTC
H
MMSI PT Raised to $101
MMSI price target raised to $101
EQUITY | Jul 31, 2026, 01:09 PM UTC
L
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results
Merit Medical Systems Inc (NASDAQ: MMSI ) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s s
EARNINGS | Jul 31, 2026, 10:43 AM UTC
H
MMSI PT Raised to $105 at BTIG
MMSI price target raised to $105
EQUITY | Jul 31, 2026, 09:44 AM UTC
H
AXTI +20%, COHU +15.7%, FND +11.2%, MPWR +9.8%, RYAN +9.1%, AMZN +8.9%, SPXC +7.8%, CDNA +5.9%, CSTL +5.2%, MMSI +4.7%, SPSC +4.7, GDYN +4.1
AXTI +20%, COHU +15.7%, FND +11.2%, MPWR +9.8%, RYAN +9.1%, AMZN +8.9%, SPXC +7.8%, CDNA +5.9%, CSTL +5.2%, MMSI +4.7%, SPSC +4.7, GDYN +4.1%, PTCT +3.3% after results
EARNINGS | Jul 30, 2026, 08:34 PM UTC
L
MMSI Merit Medical systems outlook FY non-gaap earnings per share\t$4.25 - $4.35
MMSI Merit Medical systems outlook FY non-gaap earnings per share\t$4.25 - $4.35
EARNINGS | Jul 30, 2026, 08:29 PM UTC
L
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B
Merit Medical Systems (NASDAQ: MMSI ) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 bill
EARNINGS | Jul 30, 2026, 08:09 PM UTC
L
MMSI Merit Medical Systems RESULTS: Q2, Q2 ADJ Net Income $71.3M vs. EST $58.7M, Q2 EPS $0.65, Q2 ADJ EPS $1.19 vs. EST $0.96, Merit Medical
MMSI Merit Medical Systems RESULTS: Q2, Q2 ADJ Net Income $71.3M vs. EST $58.7M, Q2 EPS $0.65, Q2 ADJ EPS $1.19 vs. EST $0.96, Merit Medical Systems Earnings Notes:, Outlook FY REV $1,631-1.643B vs. EST $1.620B
EARNINGS | Jul 30, 2026, 08:05 PM UTC
L
MMSI - Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
MMSI - Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
EARNINGS | Jul 30, 2026, 08:05 PM UTC